• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CRYOLIFE, INC. CRYOPATCH SYNERGRAFT PULMONARY HEMI-ARTERY; PATCH, PLEDGET AND INTRACARDIAC, PETP, PTFE, POLYPROPYLENE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CRYOLIFE, INC. CRYOPATCH SYNERGRAFT PULMONARY HEMI-ARTERY; PATCH, PLEDGET AND INTRACARDIAC, PETP, PTFE, POLYPROPYLENE Back to Search Results
Model Number SGPH00
Device Problem Material Separation (1562)
Patient Problems Not Applicable (3189); No Code Available (3191)
Event Date 11/15/2018
Event Type  Injury  
Manufacturer Narrative
This investigation is currently ongoing. any additional information will be provided in the follow-up report. .
 
Event Description
According to an email received on 11/16/2018: "implanted the hemi artery patch on the aortic arch.Took clamp off, pressure went to 40, center of the patch "apperared" to delaminate.Used additional patch from the same hemi artery to buttress and patch over the original patch." a phone call was made to representative on 11/20/2018 to request if the patient remained stable throughout the procedure, current patient status, and if the doctor noticed anything prior to implant that could have lead to the reported event.The representative replied: "the patient did remain stable throughout the procedure and it was successful.The doctor did not notice anything that could have led to the reported event.".
 
Event Description
According to an email received on 11/16/2018: "implanted the hemi artery patch on the aortic arch.Took clamp off, pressure went to 40, center of the patch apperared to delaminate.Used additional patch from the same hemi artery to buttress and patch over the original patch." a phone call was made to representative on 11/20/2018 to request if the patient remained stable throughout the procedure, current patient status, and if the doctor noticed anything prior to implant that could have lead to the reported event.The representative replied: "the patient did remain stable throughout the procedure and it was successful.The doctor did not notice anything that could have led to the reported event." a phone call was made to the representative on 11/22/2018 to request operative notes for the event."i have gotten all the information that i can," was the reply.
 
Manufacturer Narrative
Sample was returned form [facility] and examined on 11/29/2018.A root cause could not be determined as the graft met all specifications and no delamination occurred when the subject matter expert manipulated the tissue.All attributes identified during inspection were documented appropriately, no non-conformances were noted, and no findings were identified that could have contributed to the reported event.During the inspection of each cardiac graft, a qualified inspector wearing surgical loupes inspects the graft noting any attributes such as holes, tears, disruptions, plaque, etc.According to the processing records, this graft did not contain any attributes that would have rejected the graft.The risk management file thoroughly identifies the process and product hazards for approved indications.Each individual hazard is mitigated and reduced as low as possible by design and process.Post production residual risk is communicated in the product's labeling and ifu [instructions for use].No root cause could be identified in the manufacturer's review and all risk are identified.No action necessary.This event does not identify additional hazards or modify the probability and severity of existing hazards.This report is being submitted as required by federal regulations and does not constitute an admission that the device caused or contributed to the reported event.  furthermore, this report reflects the event as alleged by the complainant and does not imply that the information required to cryolife is accurate or has been confirmed by cryolife.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CRYOPATCH SYNERGRAFT PULMONARY HEMI-ARTERY
Type of Device
PATCH, PLEDGET AND INTRACARDIAC, PETP, PTFE, POLYPROPYLENE
Manufacturer (Section D)
CRYOLIFE, INC.
1655 roberts blvd. nw
kennesaw GA 30144
MDR Report Key8155308
MDR Text Key130057423
Report Number1063481-2018-00053
Device Sequence Number1
Product Code DXZ
Combination Product (y/n)N
PMA/PMN Number
K091626
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Type of Report Initial,Followup
Report Date 01/30/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/12/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Model NumberSGPH00
Device Catalogue NumberSGPH00
Device Lot Number145686
Was Device Available for Evaluation? No
Date Manufacturer Received11/15/2018
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
-
-